Company intelligence / Profile preview

Bleep

Chapel Hill, North Carolina, United Statesbleep.com ↗

Ownership: Private
Development stage: Other

Overview

Bleep has developed and commercialized the DreamPort®, a one-size-fits-all CPAP solution with no headgear that eliminates leaks and facial irritation. The product has FDA clearance and clinical validation for efficacy in improving patient comfort and compliance. Their next-generation Eclipse PAP interface aims to further improve usability, comfort, and reduce common issues like claustrophobia associated with traditional masks. The company recently received a $1.7 million NIH SBIR grant to optimize this technology for both home and acute care settings.

Therapeutic areas: Pulmonology
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

National Institutes of Health (NIH) – SBIR grant partnership

Beyond the preview

Go deeper on Bleep.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bleep.

Explore the full profile